Development of a factorial design for a therapeutic plasmid DNA biosynthesis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.6/3206 |
Resumo: | Therapeutic applications of plasmid DNA (pDNA) have significantly advanced during the last years. Currently, several pDNA-based drugs are already in the market, whereas several others have entered to phases 2 and 3 of clinical trials. The present and future demand for pDNA requires the development of efficient bioprocesses to produce it. Commonly, pDNA is produced by cultures of Escherichia coli. It has been previously demonstrated that specific strains of E. coli with a modified substrate transport system can be able to attain high cell densities in batch mode, due to the very low overflow metabolism displayed. However, the large amounts of oxygen demanded can lead to microaerobic conditions after some hours of cultivation, even at small-scale. Typically, the inherent problems for these cultures are the high oxygen demand and the accumulation of acetate, a metabolic by-product that is synthesized aerobically when the glucose rate exceeds limits. In recent years, various researches have been focused on the study of induction of plasmid DNA as well as strategies for fermentation using semi-defined mediums. These studies conceived relevant results that allow us to design a production platform for enhanced plasmid DNA. The main goal of this study is to optimize the yield of therapeutic plasmid DNA by culture of recent developed strain of Escherichia coli. The strategy is based on the variation of composition of the fermentation media in terms of nutrients and by a development of an experimental design directed to aromatic amino acids pathway. Monitoring through analytical methods is an advantage both in control and optimization of the intervenients in fermentation process. The change of composition and concentration of the substrates affect the growth of Escherichia coli VH33 and simultaneously, the quantity and quality of the plasmid in study. The experimental model confirms that the disturbing on the aromatic amino acid pathway influences the production plasmid DNA. |
id |
RCAP_1377635048e64bbad1f1429d81029093 |
---|---|
oai_identifier_str |
oai:ubibliorum.ubi.pt:10400.6/3206 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
|
spelling |
Development of a factorial design for a therapeutic plasmid DNA biosynthesisBiomoléculas terapêuticas - DNA plasmídicoEscherichia coli VH33 - DNA plasmídicoTherapeutic applications of plasmid DNA (pDNA) have significantly advanced during the last years. Currently, several pDNA-based drugs are already in the market, whereas several others have entered to phases 2 and 3 of clinical trials. The present and future demand for pDNA requires the development of efficient bioprocesses to produce it. Commonly, pDNA is produced by cultures of Escherichia coli. It has been previously demonstrated that specific strains of E. coli with a modified substrate transport system can be able to attain high cell densities in batch mode, due to the very low overflow metabolism displayed. However, the large amounts of oxygen demanded can lead to microaerobic conditions after some hours of cultivation, even at small-scale. Typically, the inherent problems for these cultures are the high oxygen demand and the accumulation of acetate, a metabolic by-product that is synthesized aerobically when the glucose rate exceeds limits. In recent years, various researches have been focused on the study of induction of plasmid DNA as well as strategies for fermentation using semi-defined mediums. These studies conceived relevant results that allow us to design a production platform for enhanced plasmid DNA. The main goal of this study is to optimize the yield of therapeutic plasmid DNA by culture of recent developed strain of Escherichia coli. The strategy is based on the variation of composition of the fermentation media in terms of nutrients and by a development of an experimental design directed to aromatic amino acids pathway. Monitoring through analytical methods is an advantage both in control and optimization of the intervenients in fermentation process. The change of composition and concentration of the substrates affect the growth of Escherichia coli VH33 and simultaneously, the quantity and quality of the plasmid in study. The experimental model confirms that the disturbing on the aromatic amino acid pathway influences the production plasmid DNA.As aplicações terapêuticas de DNA plasmídico (pDNA) avançaram significativamente nos últimos anos. No mercado atual é possível verificar a existência de vários compostos terapêuticos que têm como base o pDNA, estando muitos outros a ser testados nas fases 2 e 3 de ensaios clínicos. A necessidade atual e futura de pDNA implica o desenvolvimento de bioprocessos cada vez mais eficientes para a sua produção. Geralmente o pDNA é produzido por culturas de Escherichia coli. Foi previamente demonstrado que culturas específicas de E. coli que possuam um sistema de transporte do substrato alterado, que não sobrecarregue o metabolismo, são capazes de atingir altas densidades celulares. No entanto, as grandes quantidades de oxigénio exigido podem levar a condições microaeróbicas após algumas horas de cultivo, mesmo que em pequena escala. Normalmente, os problemas inerentes a estas culturas são a elevada necessidade de oxigénio e a acumulação de acetato, um subproduto metabólico que é sintetizado aerobicamente quando a taxa de captação de glicose ultrapassa um determinado limite. Nos últimos anos, várias pesquisas têm tido como foco o estudo da indução de DNA plasmídico bem como as estratégias de fermentação utilizando meios semi-definidos. Estes estudos conceberam resultados relevantes que nos permitam projetar uma plataforma de produção de DNA plasmídico otimizada. O objetivo principal deste estudo é melhorar o rendimento de produção de DNA plasmídico com potencial terapêutico através da cultura de uma estirpe de Escherichia coli recentemente desenvolvida. A estratégia baseia-se na variação da composição dos meios de fermentação em termos de nutrientes e no desenvolvimento de um desenho experimental direcionado à via metabólica dos aminoácidos aromáticos. A monitorização através de métodos analíticos válidos constitui uma vantagem, tanto no controlo como na otimização, dos intervenientes do processo fermentativo. A alteração da composição e concentração dos substratos utilizados afeta o crescimento de Escherichia coli VH33, e em simultâneo, a quantidade e qualidade do plasmídio em estudo. O modelo experimental desenvolvido confirma que a perturbação da via metabólica dos aminoácidos aromáticos influencia a produção DNA plasmídio.Passarinha, Luís António PaulinoSousa, Fani Pereira deuBibliorumMartins, Luís Miguel Candeias2015-04-08T09:21:34Z20132013-102013-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/3206TID:201008408enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-01-16T11:41:38ZPortal AgregadorONG |
dc.title.none.fl_str_mv |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis |
title |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis |
spellingShingle |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis Martins, Luís Miguel Candeias Biomoléculas terapêuticas - DNA plasmídico Escherichia coli VH33 - DNA plasmídico |
title_short |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis |
title_full |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis |
title_fullStr |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis |
title_full_unstemmed |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis |
title_sort |
Development of a factorial design for a therapeutic plasmid DNA biosynthesis |
author |
Martins, Luís Miguel Candeias |
author_facet |
Martins, Luís Miguel Candeias |
author_role |
author |
dc.contributor.none.fl_str_mv |
Passarinha, Luís António Paulino Sousa, Fani Pereira de uBibliorum |
dc.contributor.author.fl_str_mv |
Martins, Luís Miguel Candeias |
dc.subject.por.fl_str_mv |
Biomoléculas terapêuticas - DNA plasmídico Escherichia coli VH33 - DNA plasmídico |
topic |
Biomoléculas terapêuticas - DNA plasmídico Escherichia coli VH33 - DNA plasmídico |
description |
Therapeutic applications of plasmid DNA (pDNA) have significantly advanced during the last years. Currently, several pDNA-based drugs are already in the market, whereas several others have entered to phases 2 and 3 of clinical trials. The present and future demand for pDNA requires the development of efficient bioprocesses to produce it. Commonly, pDNA is produced by cultures of Escherichia coli. It has been previously demonstrated that specific strains of E. coli with a modified substrate transport system can be able to attain high cell densities in batch mode, due to the very low overflow metabolism displayed. However, the large amounts of oxygen demanded can lead to microaerobic conditions after some hours of cultivation, even at small-scale. Typically, the inherent problems for these cultures are the high oxygen demand and the accumulation of acetate, a metabolic by-product that is synthesized aerobically when the glucose rate exceeds limits. In recent years, various researches have been focused on the study of induction of plasmid DNA as well as strategies for fermentation using semi-defined mediums. These studies conceived relevant results that allow us to design a production platform for enhanced plasmid DNA. The main goal of this study is to optimize the yield of therapeutic plasmid DNA by culture of recent developed strain of Escherichia coli. The strategy is based on the variation of composition of the fermentation media in terms of nutrients and by a development of an experimental design directed to aromatic amino acids pathway. Monitoring through analytical methods is an advantage both in control and optimization of the intervenients in fermentation process. The change of composition and concentration of the substrates affect the growth of Escherichia coli VH33 and simultaneously, the quantity and quality of the plasmid in study. The experimental model confirms that the disturbing on the aromatic amino acid pathway influences the production plasmid DNA. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013 2013-10 2013-01-01T00:00:00Z 2015-04-08T09:21:34Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.6/3206 TID:201008408 |
url |
http://hdl.handle.net/10400.6/3206 |
identifier_str_mv |
TID:201008408 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1777301773138001920 |